{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:18:36Z","timestamp":1780424316099,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K08512"],"award-info":[{"award-number":["17K08512"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K21499"],"award-info":[{"award-number":["20K21499"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H04247"],"award-info":[{"award-number":["17H04247"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19ek0109297"],"award-info":[{"award-number":["JP19ek0109297"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19lm0203078h0001"],"award-info":[{"award-number":["19lm0203078h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grant-in-Aid for Scientific Research on Innovative Areas","award":["JP16H06402"],"award-info":[{"award-number":["JP16H06402"]}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020375","name":"Hamamatsu foundation for science and technology promotion","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020375","id-type":"DOI","asserted-by":"crossref"}]},{"name":"HUSM Grant-in-Aid"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      While marked reductions in neural activity and mitochondrial function have been reported in Alzheimer\u2019s disease (AD), the degree of mitochondrial activity in mild cognitive impairment (MCI) or early-stage AD remains unexplored. Here, we used positron emission tomography (PET) to examine the direct relationship between mitochondrial activity (\n                      <jats:sup>18<\/jats:sup>\n                      F-BCPP-EF) and \u03b2-amyloid (A\u03b2) deposition (\n                      <jats:sup>11<\/jats:sup>\n                      C-PiB) in the same brains of senescence-accelerated mouse prone 10 (SAMP10) mice, an A\u03b2-developing neuroinflammatory animal model showing accelerated senescence with deterioration in cognitive functioning similar to that in MCI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Five- to 25-week-old SAMP10 and control SAMR1 mice, were used in the experiments. PET was used to measure the binding levels (standard uptake value ratios; SUVRs) of [\n                      <jats:sup>18<\/jats:sup>\n                      F]2-tert-butyl-4-chloro-5-2H-pyridazin-3-one (\n                      <jats:sup>18<\/jats:sup>\n                      F-BCPP-EF) for mitochondrial complex 1 availability, and\n                      <jats:sup>11<\/jats:sup>\n                      C-PiB for A\u03b2 deposition, in the same animals, and immunohistochemistry for ATPB (an ATP synthase on the mitochondrial inner membrane) was also performed, to determine changes in mitochondrial activity in relation to amyloid burden during the early stage of cognitive impairment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The SUVR of\n                      <jats:sup>18<\/jats:sup>\n                      F-BCPP-EF was significantly lower and that of\n                      <jats:sup>11<\/jats:sup>\n                      C-PiB was higher in the 15-week-old SAMP10 mice than in the control and 5-week-old SAMP10 mice. The two parameters were found to negatively correlate with each other. The immunohistochemical analysis demonstrated temporal upregulation of ATPB levels at 15-week-old, but decreased at 25\u00a0week-old SAMP10 mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The present results provide in vivo evidence of a decrease in mitochondrial energy production and elevated amyloidosis at an early stage in SAMP10 mice. The inverse correlation between these two phenomena suggests a concurrent change in neuronal energy failure by A\u03b2-induced elevation of neuroinflammatory responses. Comparison of PET data with histological findings suggests that temporal increase of ATPB level may not be neurofunctionally implicated during neuropathological processes, including A\u03b2 pathology, in an animal model of early-phase AD spectrum disorder.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-021-02343-4","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T08:03:57Z","timestamp":1639123437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["In vivo alterations of mitochondrial activity and amyloidosis in early-stage senescence-accelerated mice: a positron emission tomography study"],"prefix":"10.1186","volume":"18","author":[{"given":"Satoru","family":"Yamagishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurika","family":"Iga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Ikegaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeharu","family":"Kakiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ohba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Fukomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1795-0614","authenticated-orcid":false,"given":"Yasuomi","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"key":"2343_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00401-009-0574-4","volume":"118","author":"E Perez-Gracia","year":"2009","unstructured":"Perez-Gracia E, Blanco R, Carmona M, Carro E, Ferrer I. Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer\u2019s disease. Acta Neuropathol. 2009;118:497\u2013504.","journal-title":"Acta Neuropathol"},{"key":"2343_CR2","doi-asserted-by":"publisher","first-page":"9695412","DOI":"10.1155\/2019\/9695412","volume":"2019","author":"I Lejri","year":"2019","unstructured":"Lejri I, Agapouda A, Grimm A, Eckert A. Mitochondria- and oxidative stress-targeting substances in cognitive decline-related disorders: from molecular mechanisms to clinical evidence. Oxid Med Cell Longev. 2019;2019:9695412.","journal-title":"Oxid Med Cell Longev"},{"key":"2343_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183\u201394.","journal-title":"J Intern Med"},{"key":"2343_CR4","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1001\/archneurol.2011.3152","volume":"69","author":"JC Morris","year":"2012","unstructured":"Morris JC. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia. Arch Neurol. 2012;69:700\u20138.","journal-title":"Arch Neurol"},{"key":"2343_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3233\/JAD-161074","volume":"57","author":"S Hatashita","year":"2017","unstructured":"Hatashita S, Wakebe D. Amyloid-beta deposition and long-term progression in mild cognitive impairment due to Alzheimer\u2019s disease defined with amyloid PET imaging. J Alzheimers Disease. 2017;57:765\u201373.","journal-title":"J Alzheimers Disease"},{"key":"2343_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/jlcr.3056","volume":"56","author":"N Harada","year":"2013","unstructured":"Harada N, Nishiyama S, Kanazawa M, Tsukada H. Development of novel PET probes, [18F]BCPP-EF, [18F]BCPP-BF, and [11C]BCPP-EM for mitochondrial complex 1 imaging in the living brain. J Labelled Compd Radiopharm. 2013;56:553\u201361.","journal-title":"J Labelled Compd Radiopharm"},{"key":"2343_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2967\/jnumed.113.125328","volume":"55","author":"H Tsukada","year":"2014","unstructured":"Tsukada H, Nishiyama S, Fukumoto D, Kanazawa M, Harada N. Novel PET probes 18F-BCPP-EF and 18F-BCPP-BF for mitochondrial complex I: a PET study in comparison with 18F-BMS-747158-02 in rat brain. J Nucl Med. 2014;55:473\u201380.","journal-title":"J Nucl Med"},{"key":"2343_CR8","doi-asserted-by":"publisher","first-page":"e1592","DOI":"10.1212\/WNL.0000000000009249","volume":"94","author":"T Terada","year":"2020","unstructured":"Terada T, Obi T, Bunai T, Matsudaira T, Yoshikawa E, Ando I, Futatsubashi M, Tsukada H, Ouchi Y. In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease. Neurology. 2020;94:e1592.","journal-title":"Neurology"},{"key":"2343_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0531-5565(96)00060-5","volume":"32","author":"K Higuchi","year":"1997","unstructured":"Higuchi K. Genetic characterization of senescence-accelerated mouse (SAM). Exp Gerontol. 1997;32:129\u201338.","journal-title":"Exp Gerontol"},{"key":"2343_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1474-9726.2008.00394.x","volume":"7","author":"T Sasaki","year":"2008","unstructured":"Sasaki T, Unno K, Tahara S, Shimada A, Chiba Y, Hoshino M, Kaneko T. Age-related increase of superoxide generation in the brains of mammals and birds. Aging Cell. 2008;7:459\u201369.","journal-title":"Aging Cell"},{"key":"2343_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2990.2006.00632.x","volume":"32","author":"A Shimada","year":"2006","unstructured":"Shimada A, Tsuzuki M, Keino H, Satoh M, Chiba Y, Saitoh Y, Hosokawa M. Apical vulnerability to dendritic retraction in prefrontal neurones of ageing SAMP10 mouse: a model of cerebral degeneration. Neuropathol Appl Neurobiol. 2006;32:1\u201314.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2343_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1440-1789.2010.01126.x","volume":"31","author":"S Hasegawa-Ishii","year":"2011","unstructured":"Hasegawa-Ishii S, Takei S, Chiba Y, Furukawa A, Umegaki H, Iguchi A, Kawamura N, Yoshikawa K, Hosokawa M, Shimada A. Morphological impairments in microglia precede age-related neuronal degeneration in senescence-accelerated mice. Neuropathology. 2011;31:20\u20138.","journal-title":"Neuropathology"},{"key":"2343_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12974-019-1604-3","volume":"16","author":"S Yamagishi","year":"2019","unstructured":"Yamagishi S, Iga Y, Nakamura M, Takizawa C, Fukumoto D, Kakiuchi T, Nishiyama S, Ohba H, Tsukada H, Sato K, Ouchi Y. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study. J Neuroinflammation. 2019;16:208.","journal-title":"J Neuroinflammation"},{"key":"2343_CR14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, et al. Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306\u201319.","journal-title":"Ann Neurol"},{"key":"2343_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neurobiolaging.2020.05.003","volume":"94","author":"AM Barron","year":"2020","unstructured":"Barron AM, Ji B, Fujinaga M, Zhang M-R, Suhara T, Sahara N, Aoki I, Tsukada H, Higuchi M. In vivo positron emission tomography imaging of mitochondrial abnormalities in a mouse model of tauopathy. Neurobiol Aging. 2020;94:140\u20138.","journal-title":"Neurobiol Aging"},{"key":"2343_CR16","doi-asserted-by":"crossref","unstructured":"Terada T, Therriault J, Kang MSP, Savard M, Pascoal TA, Lussier F, Tissot C, Wang YT, Benedet A, Matsudaira T, et al. Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease. Mol Neurodegenerat. 2021;16.","DOI":"10.1186\/s13024-021-00448-1"},{"key":"2343_CR17","doi-asserted-by":"crossref","unstructured":"Yamagishi S, Yamada K, Sawada M, Nakano S, Mori N, Sawamoto K, Sato K. Netrin-5 is highly expressed in neurogenic regions of the adult brain. Front Cell Neurosci. 2015;9.","DOI":"10.3389\/fncel.2015.00146"},{"key":"2343_CR18","doi-asserted-by":"publisher","first-page":"e31310","DOI":"10.1371\/journal.pone.0031310","volume":"7","author":"A Manook","year":"2012","unstructured":"Manook A, Yousefi BH, Willuweit A, Platzer S, Reder S, Voss A, Huisman M, Settles M, Neff F, Velden J, et al. Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP\/PS1 mouse model of Alzheimer\u2019s disease. PLoS ONE. 2012;7:e31310.","journal-title":"PLoS ONE"},{"key":"2343_CR19","first-page":"198","volume":"39","author":"Y Ouchi","year":"1998","unstructured":"Ouchi Y, Tsukada H, Kakiuchi T, Nishiyama S, Futatsubashi M. Changes in cerebral blood flow and postsynaptic muscarinic cholinergic activity in rats with bilateral carotid artery ligation. J Nucl Med. 1998;39:198\u2013202.","journal-title":"J Nucl Med"},{"key":"2343_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/(SICI)1097-0029(19981001)43:1<59::AID-JEMT9>3.0.CO;2-X","volume":"43","author":"T Kawamata","year":"1998","unstructured":"Kawamata T, Akiguchi I, Maeda K, Tanaka C, Higuchi K, Hosokawa M, Takeda T. Age-related changes in the brains of senescence-accelerated mice (SAM): association with glial and endothelial reactions. Microsc Res Tech. 1998;43:59\u201367.","journal-title":"Microsc Res Tech"},{"key":"2343_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.nbd.2016.01.001","volume":"88","author":"P Giannoni","year":"2016","unstructured":"Giannoni P, Arango-Lievano M, Neves ID, Rousset M-C, Baranger K, Rivera S, Jeanneteau F, Claeysen S, Marchi N. Cerebrovascular pathology during the progression of experimental Alzheimer\u2019s disease. Neurobiol Dis. 2016;88:107\u201317.","journal-title":"Neurobiol Dis"},{"key":"2343_CR22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","volume":"14","author":"TK Ulland","year":"2018","unstructured":"Ulland TK, Colonna M. TREM2\u2014a key player in microglial biology and Alzheimer disease. Nat Rev Neurol. 2018;14:667\u201375.","journal-title":"Nat Rev Neurol"},{"key":"2343_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL, Loboda AA, Zhou Y, Cairns NJ, Kambal A, et al. TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell. 2017;170:649\u2013663613.","journal-title":"Cell"},{"key":"2343_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/00005072-199207000-00006","volume":"51","author":"A Shimada","year":"1992","unstructured":"Shimada A, Ohta A, Akiguchi I, Takeda T. Inbred SAM-P\/10 as a mouse model of spontaneous, inherited brain atrophy. J Neuropathol Exp Neurol. 1992;51:440\u201350.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2343_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3233\/JAD-151205","volume":"53","author":"M Perkins","year":"2016","unstructured":"Perkins M, Wolf AB, Chavira B, Shonebarger D, Meckel JP, Leung L, Ballina L, Ly S, Saini A, Jones TB, et al. Altered energy metabolism pathways in the posterior cingulate in young adult Apolipoprotein E varepsilon4 Carriers. J Alzheimers Dis. 2016;53:95\u2013106.","journal-title":"J Alzheimers Dis"},{"key":"2343_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3233\/JAD-2010-100129","volume":"22","author":"J Valla","year":"2010","unstructured":"Valla J, Yaari R, Wolf AB, Kusne Y, Beach TG, Roher AE, Corneveaux JJ, Huentelman MJ, Caselli RJ, Reiman EM. Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE epsilon4 allele, the major late-onset Alzheimer\u2019s susceptibility gene. J Alzheimers Dis. 2010;22:307\u201313.","journal-title":"J Alzheimers Dis"},{"key":"2343_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.brainres.2007.09.021","volume":"1185","author":"N Kumagai","year":"2007","unstructured":"Kumagai N, Chiba Y, Hosono M, Fujii M, Kawamura N, Keino H, Yoshikawa K, Ishii S, Saitoh Y, Satoh M, et al. Involvement of pro-inflammatory cytokines and microglia in an age-associated neurodegeneration model, the SAMP10 mouse. Brain Res. 2007;1185:75\u201385.","journal-title":"Brain Res"},{"key":"2343_CR28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","volume":"173","author":"R Orihuela","year":"2016","unstructured":"Orihuela R, McPherson CA, Harry GJ. Microglial M1\/M2 polarization and metabolic states. Br J Pharmacol. 2016;173:649\u201365.","journal-title":"Br J Pharmacol"},{"key":"2343_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1083\/jcb.200207030","volume":"161","author":"HK Anandatheerthavarada","year":"2003","unstructured":"Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer\u2019s amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol. 2003;161:41\u201354.","journal-title":"J Cell Biol"},{"key":"2343_CR30","doi-asserted-by":"publisher","first-page":"29096","DOI":"10.1074\/jbc.M602532200","volume":"281","author":"A Falkevall","year":"2006","unstructured":"Falkevall A, Alikhani N, Bhushan S, Pavlov PF, Busch K, Johnson KA, Eneqvist T, Tjernberg L, Ankarcrona M, Glaser E. Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome. PreP J Biol Chem. 2006;281:29096\u2013104.","journal-title":"PreP J Biol Chem"},{"key":"2343_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JAD-2011-101716","volume":"27","author":"N Alikhani","year":"2011","unstructured":"Alikhani N, Guo L, Yan S, Du H, Pinho CM, Chen JX, Glaser E, Yan SS. Decreased proteolytic activity of the mitochondrial amyloid-beta degrading enzyme, PreP peptidasome, in Alzheimer\u2019s disease brain mitochondria. J Alzheimers Dis. 2011;27:75\u201387.","journal-title":"J Alzheimers Dis"},{"key":"2343_CR32","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","volume":"15","author":"M Manczak","year":"2006","unstructured":"Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH. Mitochondria are a direct site of A beta accumulation in Alzheimer\u2019s disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet. 2006;15:1437\u201349.","journal-title":"Hum Mol Genet"},{"key":"2343_CR33","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3233\/JAD-160953","volume":"55","author":"D Del Prete","year":"2017","unstructured":"Del Prete D, Suski JM, Oules B, Debayle D, Gay AS, Lacas-Gervais S, Bussiere R, Bauer C, Pinton P, Paterlini-Brechot P, et al. Localization and processing of the amyloid-beta protein precursor in mitochondria-associated membranes. J Alzheimers Dis. 2017;55:1549\u201370.","journal-title":"J Alzheimers Dis"},{"key":"2343_CR34","doi-asserted-by":"publisher","first-page":"51654","DOI":"10.1074\/jbc.M404500200","volume":"279","author":"CA Hansson","year":"2004","unstructured":"Hansson CA, Frykman S, Farmery MR, Tjernberg LO, Nilsberth C, Pursglove SE, Ito A, Winblad B, Cowburn RF, Thyberg J, Ankarcrona M. Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. J Biol Chem. 2004;279:51654\u201360.","journal-title":"J Biol Chem"},{"key":"2343_CR35","doi-asserted-by":"publisher","first-page":"e115789","DOI":"10.1371\/journal.pone.0115789","volume":"9","author":"VL Patterson","year":"2014","unstructured":"Patterson VL, Zullo AJ, Koenig C, Stoessel S, Jo H, Liu X, Han J, Choi M, DeWan AT, Thomas JL, et al. Neural-specific deletion of Htra2 causes cerebellar neurodegeneration and defective processing of mitochondrial OPA1. PLoS ONE. 2014;9:e115789.","journal-title":"PLoS ONE"},{"key":"2343_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2990.2007.00926.x","volume":"34","author":"RO Carare","year":"2008","unstructured":"Carare RO, Bernardes-Silva M, Newman TA, Page AM, Nicoll JAR, Perry VH, Weller RO. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol. 2008;34:131\u201344.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2343_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2012.04.021","volume":"236","author":"DR Thal","year":"2012","unstructured":"Thal DR. The role of astrocytes in amyloid \u03b2-protein toxicity and clearance. Exp Neurol. 2012;236:1\u20135.","journal-title":"Exp Neurol"},{"key":"2343_CR38","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, Holtzman DM, Zlokovic BV. apoE isoform\u2013specific disruption of amyloid \u03b2 peptide clearance from mouse brain. J Clin Investig. 2008;118:4002\u201313.","journal-title":"J Clin Investig"},{"key":"2343_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-008-0457-0","volume":"117","author":"RO Weller","year":"2008","unstructured":"Weller RO, Djuanda E, Yow H-Y, Carare RO. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol. 2008;117:1\u201314.","journal-title":"Acta Neuropathol"},{"key":"2343_CR40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic BV. The blood\u2013brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57:178\u2013201.","journal-title":"Neuron"},{"key":"2343_CR41","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrn.2017.48","volume":"18","author":"K Kisler","year":"2017","unstructured":"Kisler K, Nelson AR, Montagne A, Zlokovic BV. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci. 2017;18:419\u201334.","journal-title":"Nat Rev Neurosci"},{"key":"2343_CR42","doi-asserted-by":"crossref","unstructured":"Ewers M, Franzmeier N, Suarez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, Piccio L, Cruchaga C, Deming Y, Dichgans M, et al. Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease. Sci Transl Med. 2019;11.","DOI":"10.1126\/scitranslmed.aav6221"},{"key":"2343_CR43","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/ene.13583","volume":"25","author":"M Casati","year":"2018","unstructured":"Casati M, Ferri E, Gussago C, Mazzola P, Abbate C, Bellelli G, Mari D, Cesari M, Arosio B. Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer\u2019s disease. Eur J Neurol. 2018;25:805\u201310.","journal-title":"Eur J Neurol"},{"key":"2343_CR44","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4161\/15384101.2014.991572","volume":"14","author":"M Morita","year":"2015","unstructured":"Morita M, Gravel SP, Hulea L, Larsson O, Pollak M, St-Pierre J, Topisirovic I. mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle. 2015;14:473\u201380.","journal-title":"Cell Cycle"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02343-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-021-02343-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02343-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T13:10:20Z","timestamp":1676034620000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-021-02343-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2343"],"URL":"https:\/\/doi.org\/10.1186\/s12974-021-02343-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-27076\/v1","asserted-by":"object"}]},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,10]]},"assertion":[{"value":"25 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the ethics committees of the Central Research Laboratory at Hamamatsu Photonics and Hamamatsu University School of Medicine. The approval reference number is 2015065 and 2020051.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study involves no human materials.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"288"}}